Status:
UNKNOWN
Assessment of Arrhythmic BuRdEn With Post-ProCedural COntinuous ElectRocarDiographic Monitoring in Patients Undergoing Transcatheter Aortic Valve Implantation: The RECORD Study
Lead Sponsor:
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Conditions:
TAVI
ECG Monitoring
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
TAVI recipients exhibit a high burden of arrhythmic events early after the procedure. ECG continuous monitoring could be useful to diagnose and facilitate early implementation of specific therapeutic ...
Detailed Description
Prospective registry including patients accepted by the heart team for a TAVI procedure. Patients will undergo a prolonged continuous ECG monitoring using the CardioSTAT® device after hospital dischar...
Eligibility Criteria
Inclusion
- Patients with severe aortic stenosis undergoing TAVI with either balloon or self-expandable valves.
Exclusion
- Failure to provide informed consent.
- Prior or post-procedural pacemaker
- In-hospital death
- Logistic reasons precluding ECG monitoring within the 4 weeks after the procedure
- Participation in another continuous ECG monitoring post-TAVI trial
Key Trial Info
Start Date :
June 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04298593
Start Date
June 28 2019
End Date
December 1 2025
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IUCPQ
Québec, Canada, G1V 4G5